The Department of Comparative Medicine (DCM) -managed BSL3/ABSL3 facility is a state-of-the-art high containment research facility designed for both in vitro and in vivo research requiring biosafety level 3 (BSL3) containment, including work with select agents.
Research conducted within the facility furthers the understanding and development of vaccines, diagnostics, and treatments for potentially life-threatening infectious diseases.
The facility is available for use by UW investigators as well as external institutions.
Comments are closed.